Sales of systemic hormonal preparations (excluding sex hormones and insulins) in Germany have exhibited considerable fluctuation over the past decade. Starting at $1.39 billion in 2013, the market experienced declines and recoveries, reaching $1.56 billion in 2023. In 2023, the market registered a 2.02% year-on-year increase. The last five years show an average annual growth (CAGR) of 2.23%. By 2028, the forecast indicates steady growth with a projected CAGR of 1.48%, anticipating a market value of $1.71 billion.
Future trends to watch for include:
- Technological advancements in hormone delivery systems
- Increasing prevalence of hormonal disorders
- Regulatory changes affecting market dynamics
- Rising awareness and demand for personalized hormonal therapies
